Bio-Rad Laboratories EPS - Earnings per Share 2010-2025 | BIO

Bio-Rad Laboratories annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bio-Rad Laboratories EPS for the quarter ending March 31, 2025 was $2.29, a 82.97% decline year-over-year.
  • Bio-Rad Laboratories EPS for the twelve months ending March 31, 2025 was $-76.52, a 615.81% increase year-over-year.
  • Bio-Rad Laboratories 2024 annual EPS was $-65.36, a 199.54% increase from 2023.
  • Bio-Rad Laboratories 2023 annual EPS was $-21.82, a 82.08% decline from 2022.
  • Bio-Rad Laboratories 2022 annual EPS was $-121.79, a 186.48% decline from 2021.
Bio-Rad Laboratories Annual EPS
2024 $-65.36
2023 $-21.82
2022 $-121.79
2021 $140.83
2020 $126.47
2019 $58.27
2018 $12.10
2017 $4.07
2016 $0.88
2015 $3.71
2014 $3.05
2013 $2.69
2012 $5.78
2011 $6.29
2010 $6.59
2009 $5.20
Bio-Rad Laboratories Quarterly EPS
2025-03-31 $2.29
2024-12-31 $-25.89
2024-09-30 $23.34
2024-06-30 $-76.26
2024-03-31 $13.45
2023-12-31 $11.81
2023-09-30 $3.64
2023-06-30 $-39.59
2023-03-31 $2.32
2022-12-31 $27.24
2022-09-30 $-5.48
2022-06-30 $-31.05
2022-03-31 $-112.50
2021-12-31 $-51.83
2021-09-30 $129.96
2021-06-30 $30.32
2021-03-31 $32.38
2020-12-31 $27.96
2020-09-30 $43.64
2020-06-30 $32.15
2020-03-31 $22.72
2019-12-31 $18.35
2019-09-30 $-8.68
2019-06-30 $19.86
2019-03-31 $28.74
2018-12-31 $-27.43
2018-09-30 $8.89
2018-06-30 $8.87
2018-03-31 $21.77
2017-12-31 $2.76
2017-09-30 $0.73
2017-06-30 $0.17
2017-03-31 $0.41
2016-12-31 $-0.77
2016-09-30 $0.62
2016-06-30 $0.61
2016-03-31 $0.42
2015-12-31 $1.54
2015-09-30 $0.59
2015-06-30 $0.97
2015-03-31 $0.61
2014-12-31 $1.34
2014-09-30 $0.39
2014-06-30 $1.09
2014-03-31 $0.23
2013-12-31 $1.04
2013-09-30 $-0.25
2013-06-30 $1.20
2013-03-31 $0.70
2012-12-31 $1.51
2012-09-30 $1.49
2012-06-30 $1.69
2012-03-31 $1.09
2011-12-31 $2.11
2011-09-30 $1.61
2011-06-30 $1.41
2011-03-31 $1.16
2010-12-31 $2.41
2010-09-30 $1.59
2010-06-30 $1.35
2010-03-31 $1.24
2009-12-31 $1.35
2009-09-30 $1.38
2009-06-30 $1.37
2009-03-31 $1.10
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.723B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.616B 27.97
Boston Scientific (BSX) United States $153.611B 38.46
Stryker (SYK) United States $149.817B 31.33
EssilorLuxottica (ESLOY) France $128.259B 0.00
Medtronic (MDT) Ireland $112.441B 15.94
Lonza Group Ag (LZAGY) Switzerland $50.320B 0.00
Haleon (HLN) United Kingdom $45.596B 26.03
ResMed (RMD) United States $37.597B 28.24
GE HealthCare Technologies (GEHC) United States $34.163B 16.22
Agilent Technologies (A) United States $33.875B 22.08
Terumo (TRUMY) Japan $24.770B 32.17
Koninklijke Philips (PHG) Netherlands $22.956B 16.11
Insulet (PODD) United States $21.162B 83.07
Zimmer Biomet Holdings (ZBH) United States $18.315B 11.76
Baxter (BAX) United States $15.236B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.113B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $3.900B 17.42
Perrigo (PRGO) Ireland $3.676B 9.32
Haemonetics (HAE) United States $3.609B 16.44
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.192B 23.54
QuidelOrtho (QDEL) United States $1.976B 13.59
LeMaitre Vascular (LMAT) United States $1.875B 41.91
AtriCure (ATRC) United States $1.561B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.248B 12.67
Phibro Animal Health (PAHC) United States $1.212B 15.49
Green Thumb Industries (GTBIF) United States $1.163B 26.16
Neogen (NEOG) United States $1.081B 13.83
BioLife Solutions (BLFS) United States $1.036B 0.00
InMode (INMD) Israel $0.954B 9.62
Kestra Medical Technologies (KMTS) United States $0.757B 0.00
Owens & Minor (OMI) United States $0.669B 5.55
Maravai LifeSciences Holdings (MRVI) United States $0.662B 0.00
CeriBell (CBLL) United States $0.622B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Tilray Brands (TLRY) Canada $0.507B 0.00
Valneva SE (VALN) France $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.452B 0.00
Surmodics (SRDX) United States $0.424B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.360B 0.00
VAREX IMAGING (VREX) United States $0.344B 12.67
SNDL (SNDL) Canada $0.326B 0.00
Quanterix (QTRX) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.284B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
ZimVie (ZIMV) United States $0.263B 11.94
Sanara MedTech (SMTI) United States $0.259B 0.00
Brainsway (BWAY) Israel $0.253B 66.85
Aurora Cannabis (ACB) Canada $0.249B 73.83
Cresco Labs (CRLBF) United States $0.247B 0.00
OraSure Technologies (OSUR) United States $0.228B 0.00
Canopy Growth (CGC) Canada $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
High Tide (HITI) Canada $0.188B 0.00
Organigram Global (OGI) Canada $0.186B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.13
Omeros (OMER) United States $0.180B 0.00
Verano Holdings (VRNOF) United States $0.173B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.147B 0.00
FitLife Brands (FTLF) United States $0.129B 15.90
Apyx Medical (APYX) United States $0.098B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.088B 0.00
MacroGenics (MGNX) United States $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.075B 0.00
Agape ATP (ATPC) $0.070B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.043B 58.29
Modular Medical (MODD) United States $0.040B 0.00
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.038B 13.10
Rockwell Medical (RMTI) United States $0.027B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.015B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00